GlassScriptPhysician profile
Randal Homer
NPI 1356486021
$1,559.50
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $545 · 2022: $86.64 · 2023: $707 · 2024: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $928.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $928.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $234.09 | 2021-2024 | Ofev |
| Glaxosmithkline, LLC. | $212.77 | 2021-2023 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $202.10 | 2021-2024 | Fasenra, Tezspire |
| Regeneron Healthcare Solutions, INC. | $188.19 | 2021-2024 | Dupixent |
| Gilead Sciences, INC. | $165.73 | 2021 | |
| Electromed, INC. | $154.71 | 2022-2024 | Smartvest |
| Actelion Pharmaceuticals US, INC. | $104.86 | 2023-2024 | Opsumit, Uptravi |
| Mylan Specialty L.P. | $63.11 | 2022-2024 | Yupelri |
| Grifols USA, LLC | $50.66 | 2022-2023 | Prolastin-C Liquid |
| United Therapeutics Corporation | $40.81 | 2023-2024 | Orenitram |
| Masimo Corporation | $34.20 | 2023 | Na, Hm 38-02 Assembly |
| Viiv Healthcare Company | $25.03 | 2021 | |
| Genzyme Corporation | $21.27 | 2021 | |
| Advanced Respiratory, INC | $19.48 | 2021 | |
| Novartis Pharmaceuticals Corporation | $16.48 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $13.25 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.76 | 2023 | Glassia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randal Homer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.